Registrational Study With Omecamtiv Mecarbil (AMG 423) to Treat Chronic Heart Failure With Reduced Ejection Fraction

NCT02929329 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

8256

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: Omecamtiv Mecarbil
DRUG: Placebo
DRUG: Standard of Care

Sponsor

Cytokinetics